Literature DB >> 9293793

Early changes in fluorine-18-FDG uptake during radiotherapy.

H Hautzel1, H W Müller-Gärtner.   

Abstract

UNLABELLED: The aim of this case study was to quantify metabolic changes in tumor tissue during and directly after external radiotherapy.
METHODS: We performed six FDG-PET scans of the neck in a patient with two lymph node metastases of a papillary thyroid carcinoma and an antigranulocyte antibody scintigraphy of the same region to assess the inflammatory reaction.
RESULTS: The FDG-PET scans show an initial increase of tracer uptake in both metastases after application of 6 Gy followed by a slow but constant decline with increasing radiation dose. In the deep metastasis the FDG uptake returned to the initial level after 30 Gy total dose whereas the metabolic activity in the superficial lymph node remained high, even after 60 Gy total dose. The antigranulocyte scan demonstrated an intense inflammation in the latter metastasis.
CONCLUSION: There is an initial enhancement in metabolism induced by irradiation which is measureable by FDG-PET. With increasing dose, the metabolic activity declines constantly. The additional inflammatory reaction might contribute to the glucose uptake in irradiated tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293793

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma.

Authors:  Sue Chua; John Dickson; Ashley M Groves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09       Impact factor: 9.236

2.  Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Nobuyuki Kawai; Katashi Satoh; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 9.236

3.  Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer.

Authors:  Sophie E Vollenbrock; Francine E M Voncken; Doenja M J Lambregts; Monique Maas; Maarten L Donswijk; Erik Vegt; Leon C Ter Beek; Jolanda M van Dieren; Johanna W van Sandick; Berthe M P Aleman; Regina G H Beets-Tan; Annemarieke Bartels-Rutten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-22       Impact factor: 9.236

Review 4.  Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.

Authors:  Kazuto Harada; Dilsa Mizrak Kaya; Anthony Lopez; Hideo Baba; Jaffer A Ajani
Journal:  Ann Transl Med       Date:  2018-02

5.  Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.

Authors:  You-Jung Yang; Jin-Sook Ryu; Seog-Young Kim; Seung Jun Oh; Ki Chun Im; Heuiran Lee; Sang-Wook Lee; Kyung Ja Cho; Gi-Jeong Cheon; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-11       Impact factor: 9.236

Review 6.  Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Authors:  Valentina Berti; Lisa Mosconi; Alberto Pupi
Journal:  PET Clin       Date:  2014-04

7.  Carbon-11-methionine positron emission tomography imaging of chordoma.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Kenji Sagou; Mei Tian; Tetsuya Suhara; Susumu Kandatsu; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

8.  Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer.

Authors:  Stephen A Barnett; Robert J Downey; Junting Zheng; Gabriel Plourde; Ronglai Shen; Jamie Chaft; Timothy Akhurst; Bernard J Park; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2016-01-12       Impact factor: 4.330

9.  Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).

Authors:  Carla F M Molthoff; Bianca M Klabbers; Johannes Berkhof; Jasper T Felten; Marcelle van Gelder; Albert D Windhorst; Ben J Slotman; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2007 Nov-Dec       Impact factor: 3.488

Review 10.  Targeted molecular imaging in oncology: focus on radiation therapy.

Authors:  Sridhar Nimmagadda; Eric C Ford; John W Wong; Martin G Pomper
Journal:  Semin Radiat Oncol       Date:  2008-04       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.